1-4 of 4
David Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A028: Clinical and analytic validation of FoundationOne CDx™ for NTRK fusion-positive solid tumors in patients treated with entrectinib

Free
David Fabrizio, Coren Milbury, Wai-Ki Yip, Bahar Yilmazel, Xiaobo Bai, Juan Liao, David Smith, Christine Burns, Christine Vietz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): A028.
https://doi.org/10.1158/1535-7163.TARG-19-A028
Published: 01 December 2019
View articletitled, Abstract A028: Clinical and analytic validation of FoundationOne CDx™ for NTRK fusion-positive solid tumors in patients treated with entrectinib
Journal Articles

Abstract C71: Phase II study of maintenance therapy with pazopanib or pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following platinum-based chemotherapy.

Free
Kartik Konduri, David Smith, Natalie Compton, Denise Elmore Lockheed, Debasis Chakrabarti, Kamal Bhatt
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C71.
https://doi.org/10.1158/1535-7163.TARG-13-C71
Published: 01 November 2013
View articletitled, Abstract C71: Phase II study of maintenance therapy with pazopanib or pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following platinum-based chemotherapy.
Journal Articles

SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells

Free
Adina Vultur, Ralf Buettner, Claudia Kowolik, Wei Liang, David Smith, Frank Boschelli, Richard Jove
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (5): 1185–1194.
https://doi.org/10.1158/1535-7163.MCT-08-0126
Published: 15 May 2008
View articletitled, SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
Open the PDF for SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells in another window
Journal Articles

Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells

Free
Sangkil Nam, Ann Williams, Adina Vultur, Alan List, Kapil Bhalla, David Smith, Francis Y. Lee, Richard Jove
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (4): 1400–1405.
https://doi.org/10.1158/1535-7163.MCT-06-0446
Published: 12 April 2007
View articletitled, Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells
Open the PDF for Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells in another window